Site 6501, St Jude Children's Research Hospital — Memphis, Tennessee

Site 6501, St Jude Children's Research Hospital is a clinical research site located in Memphis, Tennessee, United States 38105.

Crixeo Clinical Trials Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Site 6501, St Jude Children's Research Hospital has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: HIV -1 Infection, HIV-1.

Sponsors: International Maternal Pediatric Adolescent AIDS Clinical Trials Group, National Institute of Allergy and Infectious Diseases (NIAID).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Memphis

Browse all research sites in Tennessee · View every site in Memphis

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 6501, St Jude Children's Research Hospital?

Site 6501, St Jude Children's Research Hospital has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 6501, St Jude Children's Research Hospital conducted?

Site 6501, St Jude Children's Research Hospital has 2 clinical trials on record, with 2 currently active. Their work covers HIV -1 Infection, HIV-1.

Is Site 6501, St Jude Children's Research Hospital accredited by Crixeo Clinical Trials?

Site 6501, St Jude Children's Research Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 6501, St Jude Children's Research Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.